Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/HCTZ vs Telmisartan in Grade 2/3 Hypertension
NCT00926289Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Telmisartan Monotherapy with Telmisartan/HCTZ Combination (2 arms). Primary endpoint: Change From Baseline in Mean Seated Trough Cuff Systolic Blood Pressure (SBP) at 7 weeks. Started Jun 2009; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00926289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00926289.